ONCOGENEX PHARMACEUTICALS IN's ticker is OGXI and the CUSIP is 68230A106. A total of 60 filers reported holding ONCOGENEX PHARMACEUTICALS IN in Q4 2014. The put-call ratio across all filers is 3.99 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $59,000 | +25.5% | 117,763 | +28.2% | 0.00% | – |
Q3 2016 | $47,000 | +1075.0% | 91,843 | +2017.7% | 0.00% | – |
Q2 2016 | $4,000 | -91.7% | 4,337 | -93.9% | 0.00% | – |
Q1 2016 | $48,000 | -48.4% | 70,872 | -7.6% | 0.00% | – |
Q4 2015 | $93,000 | -44.0% | 76,662 | +3.0% | 0.00% | – |
Q3 2015 | $166,000 | +12.9% | 74,399 | +18.1% | 0.00% | – |
Q2 2015 | $147,000 | +23.5% | 62,975 | +13.7% | 0.00% | – |
Q1 2015 | $119,000 | -11.9% | 55,385 | -6.4% | 0.00% | – |
Q4 2014 | $135,000 | -8.2% | 59,145 | +7.7% | 0.00% | – |
Q3 2014 | $147,000 | -17.9% | 54,915 | +14.3% | 0.00% | – |
Q2 2014 | $179,000 | -96.3% | 48,063 | -88.4% | 0.00% | -100.0% |
Q1 2014 | $4,854,000 | +45.3% | 412,783 | +3.0% | 0.00% | 0.0% |
Q4 2013 | $3,341,000 | -13.9% | 400,609 | -4.3% | 0.00% | 0.0% |
Q3 2013 | $3,880,000 | +7.0% | 418,576 | +13.2% | 0.00% | 0.0% |
Q2 2013 | $3,625,000 | – | 369,925 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 1,368,500 | $3,134,000 | 0.61% |
TANG CAPITAL MANAGEMENT LLC | 365,000 | $836,000 | 0.46% |
Abingworth LLP | 603,740 | $1,352,000 | 0.38% |
Cheyne Capital Management (UK) LLP | 150,000 | $338,000 | 0.09% |
Telemetry Investments, L.L.C. | 50,000 | $114,000 | 0.07% |
Rotella Capital Management, Inc. | 19,473 | $45,000 | 0.04% |
SABBY MANAGEMENT, LLC | 461,957 | $1,058,000 | 0.03% |
Nine Chapters Capital Management LLC | 113,700 | $260,000 | 0.02% |
STONERIDGE INVESTMENT PARTNERS LLC | 49,471 | $113,000 | 0.02% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 87,388 | $200,000 | 0.01% |